Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study.
Gristina V, Barraco N, La Mantia M, Castellana L, Insalaco L, Bono M, Perez A, Sardo D, Inguglia S, Iacono F, Cutaia S, Bazan Russo TD, Francini E, Incorvaia L, Badalamenti G, Russo A, Galvano A, Bazan V.
Gristina V, et al. Among authors: francini e.
Cancers (Basel). 2022 Dec 6;14(23):6013. doi: 10.3390/cancers14236013.
Cancers (Basel). 2022.
PMID: 36497493
Free PMC article.